Eigen Therapeutics
PrivateLast Round
Seed
Mar 5, 2024
Total Funding Raised
$7M
Company Overview
Eigen Therapeutics operates in Healthcare & Life Sciences and is based in Redwood City, California. Its latest recorded funding round was a Seed round in March 2024.
Eigen Therapeutics is a biotechnology company that develops AI-enabled priming therapies designed to address cancer heterogeneity and enhance the effectiveness of targeted oncology treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eigen Therapeutics Comparables
Compare Eigen Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TenSixty Bio | 75% | |
| Olio Labs | 74% | |
| Pathway Bio | 68% |
For institutional investors. Book with your work email.
Eigen Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 5, 2024 | ||||
| Seed | Dec 8, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Eigen Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Builders VC | Seed |
| SeaX Ventures | Seed |
| Mount Pleasant Ventures | Seed |
| Hawktail Management | Seed |
| ZAKA VC | Seed |
| Bioverge | Seed |
| First Round Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 8, 2022
$7M round led by First Round Capital.
For institutional investors. Book with your work email.
Eigen Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Eigen Therapeutics's valuation, stock price, and market status.
Is Eigen Therapeutics a public or private company?
Eigen Therapeutics is a private company.
What is the current stock price of Eigen Therapeutics?
Eigen Therapeutics is a private company, so its shares have no public market price. Caplight tracks Eigen Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eigen Therapeutics worth (valuation)?
Valuation information for Eigen Therapeutics is not publicly available.
Can I buy Eigen Therapeutics stock?
Eigen Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eigen Therapeutics's last funding round?
Eigen Therapeutics's most recent funding round was Seed on March 5, 2024.
Who are the main investors in Eigen Therapeutics?
Key investors in Eigen Therapeutics include ZAKA VC, First Round Capital.
Will Eigen Therapeutics IPO soon?
No public IPO plans have been announced for Eigen Therapeutics.
How can I track Eigen Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Eigen Therapeutics's shares on secondary markets.